2016 annual financial data

XTL Biopharmaceuticals 2016 Financial results

XTL Biopharmaceuticals 2016 financial results with verified reported values.

Direct answer

Revenue was 23,000 USD.

Operating income was -2,561,000 USD and net income was -2,545,000 USD.
Operating cash flow was -1,732,000 USD.
Alpha Vantage

Get free XTL Biopharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
23,000 USD
Operating income
-2,561,000 USD
Net income
-2,545,000 USD
Operating cash flow
-1,732,000 USD

Explore related company data

View all 2016 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all XTL Biopharmaceuticals financial years